The newly built complex of RRIUM, which will be under CCRUM, the apex government organization for research in Unani Medicine
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
The company sees the business reaching $100mn
Investment in R&D was Rs. 337.6 crore (8.3% of sales) for Q2 FY2023 as compared to Rs. 330 crore (8.2% of sales) for Q2 FY2022.
The USFDA has determined that the inspection classification of the facility is Voluntary Action Indicated (VAI)
Phase III trial also demonstrated a statistically significant reduction (14%) in hospitalization for any cause, bringing potential relief for patients and reducing burden on healthcare systems
Saroglitazar Mg is an investigational compound in the USA/EU, undergoing Phase 2b/3 clinical trials in patients with Primary Biliary Cholangitis and Phase 2b in patients with Non- alcoholic Steatohepatitis
Innovative Capsugel Enprotect capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelines
The company currently supplies one product to the US market that contributes low- single digit revenue to Jubilant Pharmova revenue
Results reinforce commitment to next-generation oral SERD development programme
Subscribe To Our Newsletter & Stay Updated
